Nonvolitional assessment of tibialis anterior force and architecture during critical illness by Connolly, Bronwen et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1002/mus.26049
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Connolly, B., Maddocks, M., Macbean, V., Bernal, W., Hart, N., Hopkins, P., & Rafferty, G. F. (2018).
Nonvolitional assessment of tibialis anterior force and architecture during critical illness. Muscle and Nerve.
https://doi.org/10.1002/mus.26049
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
  
Non-volitional assessment of tibialis anterior force and architecture during critical illness 
 
Bronwen Connolly PhD
1
, Matthew Maddocks PhD
2
, Victoria MacBean PhD
1
, William Bernal PhD
3
, 
Nicholas Hart PhD
3
, Philip Hopkins PhD
4
, Gerrard F Rafferty PhD
1  
1
King’s College London, Division of Asthma, Allergy and Lung Biology, Department of Respiratory 
Medicine, UK, 
2
King’s College London, Department of Palliative Care, Cicely Saunders Institute, UK,
 
3
Institute of Liver Studies, King’s College Hospital, London, UK, 
3
Lane Fox Respiratory Unit, Guy’s & 
St.Thomas’ NHS Foundation Trust, London, UK, 
4
Department of Critical Care, King’s College Hospital, 
London, UK 
 
Acknowledgements 
This study was supported by funding from the King’s Health Partners Challenge Fund (King’s Health 
Partners, London, UK), R121156.  BC is supported by the National Institute for Health Research 
(NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's 
College London.  The views expressed are those of the author(s) and not necessarily those of the 
NHS, the NIHR or the Department of Health. 
 
Abstract word count  150 
 
Manuscript word count  3534 
 
Corresponding author for reprints 
Dr Gerrard F Rafferty 
Department of Respiratory Medicine 
Second Floor, Cheyne Wing 
King’s College Hospital 
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process which may lead to
differences between this version and the Version of Record. Please cite this article as an
‘Accepted Article’, doi: 10.1002/mus.26049
This article is protected by copyright. All rights reserved.
 Skeletal muscle in critical illness 2 
 
 
 
Denmark Hill 
London, SE5 9RS 
Email: Gerrard.rafferty@kcl.ac.uk 
Tel: +44 20 3299 2082 
Fax: +44 203 299 3791 
 
Running title 
Skeletal muscle in critical illness 
 
Ethical Publication Statement 
We confirm that we have read the Journal’s position on issues involved in ethical publication and 
affirm that this report is consistent with those guidelines.   
 
Disclosure of Conflicts of Interest 
None of the authors has any conflict of interest to disclose. 
 
Keywords 
Critical illness, muscle force, architecture, ultrasound, assessment 
 
 
 
 
 
 
 
Page 2 of 29
John Wiley & Sons, Inc.
Muscle & Nerve
This article is protected by copyright. All rights reserved.
 Skeletal muscle in critical illness 3 
 
 
 
ABSTRACT 
Non-volitional assessment of tibialis anterior force and architecture during critical illness 
 
Introduction 
Contemporaneous measures of muscle architecture and force have not previously been conducted 
during critical illness to examine their relationship with intensive care unit (ICU)-acquired weakness. 
Methods 
Ankle dorsiflexor muscle force (ADMF) using high frequency electrical peroneal nerve stimulation 
and skeletal muscle architecture via ultrasound were measured in 21 of adult, critically ill patients, 
16 at ICU admission. 
Results 
Thirteen patients were measured on two occasions.  Of these 10 measured at ICU admission 
demonstrated muscle weakness.  Despite significant reductions in tibialis anterior (TACSA, Δ=-
88.5±78.8mm
2
, p=0.002) and rectus femoris (RFCSA, Δ=-126.1±129.1mm
2
, p=0.006) cross-sectional 
area between occasions, ADMF did not change (100HzAD (9.8 (8.0-14.4)kg vs. 8.6 (6.7-19.2)kg, 
p=0.9).   
Discussion 
Muscle weakness was evident at ICU admission.  No further decrements were observed seven days 
later despite significant reductions in muscle size.  These data suggest that not all ICU weakness is 
truly ‘acquired’, and questions our understanding of muscle function during critical illness. 
Keywords 
Critical illness, muscle force, architecture, ultrasound, assessment 
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INTRODUCTION 
Peripheral skeletal muscle wasting is an acute insult of critical illness 
1
, and may contribute to the 
development of intensive care unit-acquired weakness (ICU-AW).  Recent data from a longitudinal 
prospective cohort study of survivors of acute respiratory distress syndrome demonstrated that 
patients with ongoing ICU-AW at hospital discharge had worse 5 year survival than those without 
weakness. 
2
  Ultrasound has increasingly been used to assess muscle function by measuring 
parameters of muscle architecture such as cross-sectional area (CSA) and echogenicity. 
3
  Sequential 
measurements of CSA have previously demonstrated a reduction of almost 20% in muscle bulk in 
critically ill patients during the first ten days of ICU admission. 
1
  Furthermore, when comparing 
ultrasound-derived echogenicity data (a machine-generated parameter
4
) to histological specimens, 
echogenicity was reported to have a predictive capacity for development of myofiber necrosis 
5
, a 
clinically-relevant finding.   
 
Such measurements of peripheral skeletal muscle architecture do not, however, provide information 
on contractile properties and force-generating capacity of muscle.  Volitional manual muscle testing 
is restricted to patients sufficiently conscious to perform testing and cannot distinguish true loss of 
muscle strength from poor motivation and impaired cognition. 
6,7
  In contrast non-volitional 
techniques involving electrical or magnetic motor nerve stimulation eliminate the limitations 
imposed by patient cooperation, motivation and the clinical environment.  Non-volitional 
measurements of muscle contractility in critically ill patients have been reported for adductor pollicis 
8-10
, tibialis anterior 
11,12
, and quadriceps
13
 muscle groups albeit acquired using either the single 
twitch response or trains of up to four stimuli and therefore not reflecting true muscle strength.  
100Hz electrical stimulation of the peroneal nerve is tolerable in healthy subjects and patients with 
chronic obstructive pulmonary disease (COPD) 
14,15
 and, unlike other non-volitional techniques 
8,11,12,9,10,13
 the evoked tetanic contraction force reflects true muscle strength, being equal to that 
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obtained during a maximal voluntary contraction. 
16,15
  In addition, assessment of ankle dorsiflexor 
muscle force (ADMF) is minimally disruptive to patient position or treatment and therefore relatively 
easy to apply in the ICU environment.   
 
The aim of this study was to measure the degree and trajectory of change in peripheral skeletal 
muscle strength in patients admitted to ICU by measuring ADMF, and its relationship with 
contemporaneous assessment of peripheral skeletal muscle (tibialis anterior) architecture.  
 
METHODS 
Ethics Approval 
Ethical approval was granted (National Research Ethics Committee London – Camden & Islington, 
13/LO/02630) and the study conformed to the standards set by the Declaration of Helsinki (1996).  
Written informed assent for participation was obtained from all participants’ nominated next of kin 
or medical consultant.   
 
Study design and setting 
The study was undertaken in three tertiary referral ICUs (Liver, Medical, Surgical) of a university 
teaching hospital.  Measurements were performed in patients on two occasions, separated by seven 
days.   
    
Participants 
Adult (≥18years) patients admitted to ICU and likely to require invasive mechanical ventilation for at 
least 48hours and remain in the ICU for 7 days, were eligible for inclusion.  Patients could be 
recruited at any point during ICU admission.  Exclusion criteria included acute neurological 
diagnoses, chronic neuro- or myo-pathies, receipt of neuromuscular blocking agents, trauma injuries 
(precluding lower limb strength assessment) and pregnancy.  The right leg was assessed unless 
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impaired by clinical factors at the time of initial testing.  The same leg was used for reassessment. All 
patients received standard physical therapy during ICU admission, at the autonomous discretion of 
their treating therapist.  Typically this involved functional mobilisation activities; electrical muscle 
stimulation and in-bed cycle ergometry were not employed.      
 
Ankle dorsiflexor muscle force 
The equipment has been described previously 
14,15
; for full details see the Online Supplement 
(Section E1).  Briefly, ADMF was measured using a bespoke testing device into which the distal lower 
leg was secured.  ADMF elicited by supramaximal electrical stimulation of the common peroneal 
nerve was measured using a strain gauge attached to the underside of the device footplate.  Force 
response to single twitch (TwAD) and 1second trains of electrical stimulation at 5, 10, 20, 30, 40, 50, 
80 and 100Hz (100HzAD) were recorded.  Stimulation at half maximal tetanic tension and the 
maximal relaxation rate (MRR) of the twitch response were determined.  The mean±SD between-
occasion coefficients of variation for TwAD and 100HzAD were 6.5±1.7% and 3.5±0.7% respectively. 
 
Ultrasound imaging of peripheral skeletal muscle 
Tibialis anterior (TA) and quadriceps rectus femoris (RF) muscle cross-sectional area, pennation 
angle, echogenicity and subcutaneous thickness were assessed by an experienced investigator (BC) 
using real-time B-mode ultrasound 
14,1,15
.  Ultrasound imaging techniques are summarised below 
with full details in the Online Supplement (Section E2) 
 
Tibialis anterior  
Images of TA cross-sectional area (TACSA), pennation angle (TAPA), echogenicity (TAEI) and 
subcutaneous thickness (TASCthickness) were acquired using a 2-6MHz curvilinear and 4-12MHz linear 
(pennation angle only) transducer (C6-2 and L12-4 respectively, Philips Sparq Ultrasound System, 
Philips Healthcare, MA, USA) from the superior aspect of the distal lower limb at a point one-third of 
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the distance from the tibial plateau to the lateral malleolus, with the participant semi-supine, the 
knee supported in passive extension and the foot supported in neutral 
17-19
.  Oblique cross-sectional 
imaging was minimised by the operator using visual inspection to obtain the smallest cross-sectional 
area.  Scanning depth of TA was set to where the deep margin of the muscle could be visualized 
between the tibia and fibula.   
 
Quadriceps rectus femoris  
Imaging of RF muscle architecture (RFCSA, RFEI, RFPA, RFSCthickness) was performed in a similar manner 
(Online Supplement, Section E2), with the quadriceps muscle measured at a point two-thirds of the 
distance from the anterior superior iliac spine and the superior patellar border.  Visualisation of the 
femur was used to assist scanning depth.  RFPA was imaged with the probe rotated 90°, and the 
average value from five individual fibre angles determined.     
 
STATISTICS 
Data were tested for normality and expressed as either mean±SD or median (IQR).   Differences in 
ADMF and architecture parameters between testing occasions were determined with (Wilcoxon 
signed-rank tests.).  Predicted values and cut-offs for 100HzAD were determined from a regression 
model derived in similarly aged healthy controls
14
: 100HzAD(kg) = 4.431 + -0.116age + 0.030 TACSA - 
0.389 if female.  Muscle weakness in critically ill patients was defined as 1.645 residual standard 
deviations below the predicted value derived from 100HzAD responses from healthy subjects.  
Thresholds of losses in cross-sectional area exceeding 9.24%
20
 and 3.48%
18
 were used to define 
muscle wasting in RF and TA muscles respectively.  Relationships between ADMF and TA muscle 
architecture were assessed using Spearman’s correlation analysis.  A p value less than 0.05 was 
considered statistically significant.  Data were analysed using SPSS (SPSS Inc, Chicago, IL, US) and 
GraphPad Prism (v6 for Windows, GraphPad, La Jolla, CA, US).   
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RESULTS 
Participants 
Twenty-five patients were recruited between June 2013 and July 2014.  Three patients were unable 
to undergo testing due to clinical deterioration between recruitment and testing (n=1 death, n=1 
post-tracheostomy procedure, n=1 post-extubation).  One further patient was unable to complete 
assessment due to withdrawal of personal consultee advice.  Of the remaining 21 patients enrolled, 
16 underwent initial testing within 24hours of ICU admission.  Characteristics of the cohort are 
presented in Table 1.  By the second testing occasion, 3 patients had died, 1 patient refused consent 
for ongoing participation, and in 4 patients a deterioration in clinical status precluded testing.  
Overall 13 patients were reassessed on the second occasion (10 (76.9%) with initial testing at ICU 
admission).  All patients were intubated on the first testing occasion.  Five of the 13 patients tested 
on the second occasion had been extubated but remained on the critical care unit. 
 
Ankle dorsiflexor muscle force 
No adverse events occurred during testing, and measurement of ADMF was feasible and well 
tolerated by all patients.  In the overall cohort of 21 patients, TwAD and 100HzAD were 3.0(2.2-
4.2)kg and 10.5(8.8-15.2)kg respectively.  There was no difference in TwAD or 100HzD between 
patients recruited at or during ICU admission (Table 2).  In the 13 patients with repeat 
measurements there was no change in TwAD, 100HzAD, or TwAD and 100HzAD normalised to TACSA, 
between testing occasions (Table 3, Figure 1).  Complete force-frequency curves were obtained in all 
patients at initial testing and in 12/13 patients on the second testing occasion when one patient was 
measured at 100Hz only (Figure 2).  Summary values for the whole cohort at initial and second 
testing occasions are shown in Figure 3.  There was no difference in stimulation frequency for half-
maximal tetanic contraction or MRR on the first testing occasion compared to the second.   
 
Tibialis anterior and quadriceps rectus femoris muscle architecture 
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No differences in muscle architecture for TA and RF were observed between patients recruited at or 
during ICU admission (Table 2).  In patients with repeat assessments (Table 3) it was not possible to 
measure RF muscle architecture in one patient on either day due to obesity, and RFPA could not be 
accurately measured in four patients.  Significant reductions were observed in both TACSA between 
testing occasions, equivalent to overall percentage reductions of -9.6±9.5% and -17.2±15.5% 
respectively.  Individual trajectories of change for both muscle groups are presented in the Online 
Supplement (Section E3). 
 
Wasting, as defined above, was observed in 10/12 (83.3%) patients for RF and 10/13 (76.9%) 
patients for TA muscles between testing occasions.  Wasting of both muscle groups was observed in 
eight patients, isolated wasting of RF in two patients and of TA in one patient.  One patient did not 
demonstrate wasting in either muscle group.  ADMF was compared between patients presenting 
with and without TA muscle wasting.  No difference in measures of TwAD or 100Hz AD were evident 
(Online Supplement, Section E4).  Presence of chronic comorbidity also did no differ between those 
patients with and without TA wasting.  Significant reductions were observed in both RF muscle 
echogenicity and echogenicity standard deviation between testing occasions (Table 3).  No other 
changes RF or TA muscle architecture echogenicity were observed.    
 
Relationships between ADMF and tibialis anterior muscle architecture 
Positive correlations were observed between TACSA and RFCSA on testing occasion 1 (Spearman’s 
r=0.7, p=0.01) and 2 (Spearman’s r=0.6, p=0.045) (Online Supplement, Section E4).  Only 100HzAD 
and TACSA demonstrated a significant relationship on the second testing occasion (Spearman’s r=0.6, 
p=0.047; Online Supplement, Section E5).  No other relationships were observed.     
 
Predicted weakness  
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Using the previously described regression model, predicted values for 100HzAD were determined in 
19 of the 21 patients of the main cohort (n=2 missing TACSA data); observed 100HzAD was found to 
be significantly lower than predicted 100HzAD (Table 2), and weakness was evident in 16 (84.2%) 
patients.  A similar pattern was evident when examining the 16 patients from the main cohort who 
were tested within 24hours of ICU admission.  Fourteen patients (same n=2 missing data) had 
significantly reduced 100HzAD compared to predicted (Table 2), with 12 patients demonstrating 
weakness.   
 
Predicted 100HzAD values were also determined for the 13 patients assessed on both occasions.  
ADMF weakness was observed in 12 patients on testing occasion one and in 11 patients on occasion 
two.  On both occasions 100HzAD was significantly lower than predicted  
 
DISCUSSION 
In this study involving contemporaneous measures of muscle strength and architecture, significant 
ankle dorsiflexor muscle weakness was observed in critically ill patients on admission to ICU.  
Despite significant reductions in TACSA during the critical illness course, no further decrements in 
ADMF were observed.  Although changes in cross-sectional area were observed in both proximal 
(RF) and distal (TA) lower limb muscles, only RF showed changes in muscle quality.   
 
Our data suggest antecedent decline in force-generating capacity prior to ICU admission.  The 
reduced strength on ICU admission could therefore reflect a combination of the development of 
critical illness as well as the presence of chronic comorbidity.  This, in combination with absence of 
further decline in muscle force during the admission period, challenges the commonly accepted 
term of ICU-acquired weakness.  Certainly this presentation is a clinical diagnosis of exclusion 
following treatment of all identifiable causes including the ICU-admission diagnosis. 
21
  Nonetheless 
weakness developing pre-ICU admission is also a feature.  ‘Critical illness-associated weakness’ may 
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be a more reflective term; further investigation in larger cohorts of patients with varying degrees of 
pre-existing weakness would be valuable.  These data also suggest that other mechanisms such as 
changes within the central nervous system resulting in impaired muscle recruitment and reduced 
volitional muscle strength could be important in explaining the profound impairment observed in 
many survivors of critical illness.
22,23
 
 
We have confirmed previous findings of reduced muscle contractility in sedated and ventilated 
critically ill patients. 
8,11,12,9,10,13
  Longitudinal, as well as cross-sectional, measurements were 
performed in the current study and most initial testing was undertaken on day one of ICU admission.  
Such measures allowed not only characterisation of the underlying level of muscle weakness at ICU 
admission but also the ongoing impact of ICU stay.  Our data have demonstrated that the initial 
insult of critical illness on muscle force occurs early, possibly prior to hospitalisation, and does not 
continue to the same degree during the illness course.  We cannot, however, exclude changes in 
muscle function that occurred immediately on entry to ICU prior to assessment of skeletal muscle 
function.  We also observed no consistent relationship between peripheral skeletal muscle size and 
force at either time points of assessment.  This could be as a result of a small sample size resulting in 
type II error, but also indicative of a limitation of the ultrasound technique.   
 
Previous studies from this laboratory and others have demonstrated relationships between muscle 
size and strength in the knee extensor 
24,25
 and ankle dorsiflexor muscles 
14,15
 of COPD patients and 
age-matched control subjects.  Nonetheless, muscle CSA does not fully account for variation in 
muscle strength.  Although the current ultrasound findings mirror previously reported declines in 
such parameters in ICU patients 
3
, ultrasonographic evaluation of muscle architecture solely reflects 
morphological features.  Therefore the effects on muscle CSA of changes in lean muscle mass which 
are thought to occur during ICU admission could be masked by intrinsic alterations in muscle 
properties including infiltration of fat, fibrous tissue or extracellular fluid 
26,4,27
.  It is possible that 
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clinical procedures (sedation, neuromuscular blockade), immobilisation and altered fluid balance 
during the acute phase of critical illness lead to an overestimation of CSA on D1 and would also 
explain the significant reductions in muscle CSA that were observed between D1 and D7 of 
admission despite no change in muscle strength.  Furthermore this could also explain why a 
significant relationship between ADMF and TACSA was only observed at the second assessment, later 
in the ICU stay. 
 
Despite significant reductions in RFCSA and TACSA there were no reductions in 100HzAD.  Differential 
atrophy of lower limb muscles has been demonstrated during prolonged bed rest 
28
 and the 
predominant slow twitch fiber profile of the TA compared to RF 
29
 may result in different responses 
in muscle architecture to the critical illness process.  Such changes do not however explain the 
absence of change in muscle strength despite reductions in TACSA.  No changes were observed in TA 
echogenicity, half maximal tetanic tension or MRR between testing occasions, which may have been 
expected if substantial changes in muscle quality
4
 or muscle fiber composition had occurred. 
30-32
  It 
is also noteworthy that although TwAD was similar to that reported previously by our group for 
healthy elderly adults of a comparable age 
14
, TwAD:100HzAD was also increased.  Such data 
highlight the limitations of the 1Hz twitch technique 
33-35
.   
 
Our cohort were a highly selected, non-sequential convenience sample determined by consultee 
assent and investigator availability.  Whilst this limits generalisability, the cohort sizes were larger 
than any previous studies examining sequential changes in neuromuscular ultrasound properties in 
critically ill patients 
36,37
 or that involved non-volitional assessment of skeletal muscle strength 
12,13,38
.  
Nonetheless we acknowledge the small sample may yield unexpected findings, and that only 
approximately two-thirds of the cohort underwent repeat testing.  Half of the attrition was, 
however, due to unmodifiable reasons of patient death or lack of consent.  These occurrences, in 
combination with deteriorating clinical status in some patients, serve to highlight the overall 
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challenges associated with studying this particular patient group.  It is important to note that more 
than three-quarters of patients in the overall cohort, and those who underwent testing on both 
occasions, were recruited within 24hours of ICU admission.   
 
Animal studies have previously shown decrements in force generating capacity following prolonged 
immobilization 
39-41
.  Translating such findings to interpret our data is not straightforward.    Unlike 
studies examining disuse atrophy in models employing healthy animals, the ICU patients studied 
were not fit and healthy prior to ICU admission and all had multiple comorbidities.  The weakness 
observed at ICU admission most likely reflects the patients’ previous physical condition as well as 
any acute insult of critical illness necessitating ICU admission.  Quadriceps contractility has been 
shown to be four times lower in ICU patients with pre-existing sickness compared to healthy subjects 
but only two times lower than COPD patients 
13
.  The subsequent lack of change in skeletal muscle 
strength may also reflect opposing effects of immobilization, resolution of critical illness, or the 
influence of physical activity, via voluntary or involuntary movements, or focused physical 
rehabilitation.  The lack of change in 100HzAD may also have been due to a ‘floor effect’ and the 
inability of patients to weaken further i.e. given the already reduced baseline muscle strength 
further weakness was not possible.  .  This was, however, a relatively small physiological study in a 
heterogenous ICU population.  Larger studies are therefore highly recommended to validate these 
findings and examine the magnitude and trajectory of change in muscle strength across differing 
phenotypes of critically ill patients.  Nonetheless these data still question our knowledge around 
how muscle behaves in the context of critical illness across the spectrum of patients admitted to the 
ICU, and whether all patients truly ‘acquire’ weakness in the ICU.   
 
Whilst the current study used the trace method to assess muscle echogenicity,  Cartwright et al 
36
 
defined their ROI as a 2x2cm portion within the muscle, and Grimm et al 
42
 adopted the Heckmatt 
grading scale.  The trace method was adopted as it offered a standardised approach which reflects 
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changes across the entirety of muscles evaluated regardless of size and avoids sampling from 
adjacent muscle groups
43
, and the influence of ROIs located in different portions of the muscle CSA 
image. 
44
  In the current study, the same experienced investigator (BC) performed all ultrasound 
measurements.  Further data are, however, required to determine the clinical relevance of 
echogenicity findings e.g. indicating myofiber necrosis 
5
 as well as the significance of measures of 
CSA obtained early in critical illness.   
 
We assessed changes in muscle composition, using echointensity analysis 
4
 alongside measurement 
of  CSA as reductions in lean muscle mass could be masked by infiltration of fat, fibrous tissue or 
extracellular fluid. 
27,4,26
  Echointensity findings for TA and RF muscles differed to previously reported 
studies in critical care patients where changes analogous to mild muscle breakdown and disruption 
of normal muscle architecture akin to myopathy were noted 
36,42
, albeit these findings required 
muscle biopsy data for substantiation.   
 
We applied muscle-specific thresholds for determining wasting of both TA 
18
 and RF 
20
 muscles, 
albeit only the latter were derived from a critically ill population.  Nonetheless this approach reflects 
a more accurate method for classification, avoiding assumptions that peripheral skeletal muscle 
groups with differing location (either proximal or distal), fiber type composition and function 
demonstrate similar rates of wasting.  Determining which peripheral muscle group best reflects 
patient status overall is unclear.  Fiber type composition is not uniform across all muscle groups 
29
 
and this limits the assumption of extrapolating weakness in one muscle, to be representative of a 
generalised peripheral skeletal muscle weakness effect.  Assessment of quadriceps function, might 
be considered more ‘functionally’ relevant 
13
, than tibialis anterior however the patient repositioning 
required to measure quadriceps twitch tension is not unsubstantial in contrast to that required to 
assess ADMF, which requires minimal patient disturbance.  Volitional scores of global muscle 
strength such as  the Medical Research Council Sum-score used to diagnose ICU-AW 
21
, also omit key 
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muscle groups important for upper limb function and dexterity such as the hand muscles
45
.  We 
defined weakness using a regression equation incorporating values of TACSA, age and sex 
14
, 
determined in age-matched healthy subjects.  The relationship between muscle cross-sectional area 
measured using ultrasound and strength has not been extensively investigated in critically ill 
patients.  However we recognise that under such circumstances, the disease pathology, severity of 
acute illness and influence of various medical interventions may result in the relationships between 
muscle size and strength observed in healthy subjects no longer being entirely valid in this patient 
population.  We also reported data for healthy individuals to demonstrate acceptable levels of inter-
occasion coefficients of variation and infer confidence in the ADMF technique.  Acquiring such 
reliability data (either intra-observer, inter-observer or inter-occasion) may not be feasible in the 
critically ill patient population, where changes in clinical status would influence the results.  This in 
turn, highlights that variance evident in 100HzAD in the current study must be related to the nature 
of the clinical condition of patients.    
 
CONCLUSION 
Reduced force-generating capacity was evident in critically ill patients even on day one of ICU 
admission.  No further decrements in ADMF were observed after one week despite the presence of 
significant reductions in TACSA.  These data contribute to our understanding of the individual 
trajectories of change in peripheral skeletal muscle during critical illness and the potential 
mechanism underlying such changes.  Whilst use of ultrasound offers a clinically useful tool for 
monitoring parameters of muscle architecture, these data fail to provide a true physiological 
assessment of the functional status of the muscle.   
 
ABBREVIATIONS LIST 
ICU-AW, intensive care unit-acquired weakness; ICU, intensive care unit; COPD, chronic obstructive 
pulmonary disease; CSA, cross-sectional area; ADMF, ankle dorsiflexor muscle force; TwAD, single 
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twitch ankle dorsiflexor force; 100HzAD, 100Hz ankle dorsiflexor force; MRR, maximum relaxation 
rate; TACSA, tibialis anterior cross-sectional area; RFCSA, rectus femoris cross-sectional area; APACHE, 
acute physiology and chronic health evaluation; ROI, region of interest 
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FIGURE LEGENDS 
Figure 1.  Change in ankle dorsiflexor force (100HzAD) between testing occasions (n=13).  n=13 
patients assessed on each occasion 
 
Figure 2.  Individual force-frequency curves for patients assessed on first (n=13) and second (n=12) 
testing occasion.  Left panel, n=13 first testing occasion; Right panel, n=12, second testing occasion 
Abbreviations: TwAD – single twitch ankle dorsiflexor muscle force 
 
Figure 3.  Force frequency responses of the ankle dorsiflexors with 1 s trains of supramaximal 
electrical peroneal nerve stimulation at 5-100Hz.  Top panel shows an example trace, including single 
twitch response, and bottom panel the mean (SD) ankle dorsiflexor muscle force for critically ill 
patients measured at the first testing occasion (filled circles) and second testing occasion (open 
squares).  Points at bars represent values for mean and standard deviation respectively.  First testing 
Page 20 of 29
John Wiley & Sons, Inc.
Muscle & Nerve
This article is protected by copyright. All rights reserved.
 Skeletal muscle in critical illness 21 
 
 
 
occasion, n=13, normalised ADMF (%100HzAD) per stimulation frequency: 5Hz, 30.6±14.1; 10Hz, 
46.7±20.1; 20Hz, 68.8±21.0; 30Hz, 82.4±16.1; 40Hz, 85.3±18.9; 50Hz, 91.7±13.8; 80Hz, 93.3±13.7.  
Second testing occasion, n=12, normalised ADMF (%100HzAD) per stimulation frequency: 5Hz, 
33.4±12.6; 10Hz, 53.3±16.8; 20Hz, 72.1±20.8; 30Hz, 81.7±14.8; 40Hz, 88.2±10.7; 50Hz, 94.7±10.4; 
80Hz, 98.7±5.4.  Abbreviations: ADMF – ankle dorsiflexor muscle force 
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TABLES 
Table 1.  Clinical characteristics of patients 
Characteristic  Whole cohort 
(n=21) 
Patients recruited 
within 24hours ICU 
admission (n=16) 
Patients tested on 
both occasions (n=13) 
Age (years) 66.7±15.9 72.2±12.0 66.2±15.3 
Sex (M:F) 20:1 15:1 12:1 
Chronic co-morbidity*  
Cardiac 
Respiratory 
Liver 
Renal 
Other  
 
12 (57.1) 
5 (23.8) 
4 (19.0) 
2 (9.5) 
5 (23.8) 
 
10 (62.5) 
4 (25.0) 
1 (6.3) 
1 (6.3) 
5 (31.3) 
 
7 (53.8) 
4 (30.8) 
1 (7.7) 
1 (7.7) 
5 (38.5) 
APACHE II  23.1±5.7 23.6±6.2 21.9±6.5 
SOFA score
# 
12.4±3.2 11.8±2.7 12.0±2.7 
MOF
#
 19 (90.5) 16 (100.0) 12 (92.3) 
BMI (kg/m
2
) 22.1 (21.2-23.1) 22.0 (21.2-23.7) 22.5 (21.4-23.1) 
Admission category  
Medical  
Surgical 
 
18 (85.7) 
3 (14.3) 
 
15 (93.8) 
1 (6.2) 
 
10 (76.9) 
3 (23.1) 
ICU LOS (days) 13.0 (9.0-25.5) 12.0 (8.0-26.8) 12.0 (8.0-46.0) 
Hospital LOS (days)~ 58.1±51.4 61.6±54.6 57.1±54.0 
Survival 
ICU 
Hospital 
 
14 (66.7) 
12 (57.1) 
 
11 (68.8) 
9 (56.3) 
 
9 (69.2) 
9 (69.2) 
Between testing occasions (n=13) 
MV (days) 5.0±2.7 
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MOF (days) 7.0 (5.0-7.0) 
SOFA score** 9.6±3.4 
Pharmacotherapy (number of patients; days) 
Inotropes  
Vasopressors 
Sedation  
Analgesia  
NMBA 
Steroids  
 
11; 4.4±2.4 
4; 0.0 (0.0-1.5) 
12; 5.0±1.8 
12; 4.8±1.9 
0;  
0;  
Renal replacement therapy 7 (53.8%) 
Fluid balance (l)** 5.9±5.8 
Blood glucose level (mg/dl))** 126.0±28.8 
Insulin (IU)** 111.0 (91.5-262.0) 
Creatinine (mg/dl)** 1.4 (1.0-2.0) 
Blood urea nitrogen (mg/dl)** 30.0±14.3 
Data reported as mean±SD, median (interquartile range) or n (%).  *Chronic comorbidities reflect all comorbidities reported in patients, 
therefore sum exceeds cohort number.  
#
At ICU admission.  ~Indicates post-ICU discharge hospitalisation.  **SOFA score, blood glucose 
level, insulin, creatinine and urea are group average values of individual average daily values between testing occasions; fluid balance is 
the average individual cumulative fluid balance between testing occasions.         
 
Abbreviations: APACHE – acute physiology and chronic health evaluation.  SOFA = sequential organ failure assessment.  MOF = multi-organ 
failure.  BMI = body mass index.  ICU = intensive care unit.  LOS = length of stay.  MV = mechanical ventilation.  CVVHF = continuous venous-
venous haemofiltration.  NMBA = neuromuscular blocking agents  
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Table 2.  Ankle dorsiflexor muscle force and peripheral skeletal muscle architecture in patients  
Parameter Recruited within 24hours ICU 
admission (n=16) 
Recruited after Day 1 of ICU 
admission (n=5) 
TwAD (kg) 3.3 (2.6-4.3) 1.7 (1.2-10.4) 
100HzAD (kg) 9.8 (8.9-16.0) 8.4 (2.4-12.5) 
100HzADpred (kg) 20.67 (16.5-23.6)
# 
23.4 (19.5-27.4) 
100HzAD%pred (%) 56.0 (44.1-63.8)
# 
30.5 (10.4-60.1) 
TwAD/MRR (kg/s)  0.002 (0.002-0.003) 0.001 (0.0007-0.002) 
TACSA (mm
2
)  853.3 (704.3-1043.0) 824.7 (692.2-1082.0) 
TAEI (AU)  47.5 (42.0-51.8) 47.0 (29.7-49.0) 
TAEI(SD) (AU)  30.6 (27.8-33.4) 23.2 (18.2-35.2) 
TAPA (°)  7.5 (6.9-8.1) 6.9 (6.6-7.2) 
TASCthickness (cm)  3.3 (2.6-4.3) 4.6 (3.1-5.4) 
TwAD/TACSA (g/mm
2
) 3.9 (2.8-5.1) 1.5 (1.2-17.0) 
100HzAD/TACSA (g/mm
2
) 13.4 (10.5-16.6)  11.4 (3.1-57.2) 
TwAD:100HzAD 0.3 (0.2-0.4) 0.3 (0.2-0.4) 
RFCSA (mm
2
)  638.2 (521.0-747.6) 628.8 (373.5-1051.0) 
RFEI (AU)  52.0 (43.5-59.4) 55.6 (48.4-59.6) 
RFEI(SD) (AU)  29.1 (24.8-34.4) 32.8 (23.4-33.7) 
RFPA (°) 7.6 (7.1-8.4)  7.5 (6.1-8.4) 
RFSCthickness (cm) 0.8 (0.6-1.0) 1.4 (0.8-1.8) 
Data are presented as mean±standard deviation or median (interquartile range).  *
#
n=14 due to missing 100HzAD data (n=1) and missing 
TACSA data (n=1) for inputting into prediction equation.  100HzAD for n=15 patients, 9.8 (8.9-16.0)kg; significantly lower than predicted 
values (p=0.0001). 
 
Abbreviations: TwAD = twitch ankle dorsiflexor force.  100HzAD = 100Hz ankle dorsiflexor flexor force.  MRR = maximum relaxation rate.   
TACSA = tibialis anterior cross-sectional area.  TAEI(SD) = tibialis anterior echogenicity (standard deviation).  TAPA = tibialis anterior pennation 
angle.  TAsc thickness = tibialis anterior subcutaneous thickness.  RFCSA = rectus femoris cross-sectional area.  RFEI(SD) = rectus femoris 
echogenicity (standard deviation).  RFPA = rectus femoris pennation angle.  RFsc thickness = rectus femoris subcutaneous thickness 
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Table 3.  Ankle dorsiflexor muscle force and peripheral skeletal muscle architecture on repeat 
occasions 
Parameter Testing occasion 1         Testing occasion 2         Δ  p 
TwAD (kg) 2.9 (2.0-3.6) 3.0 (2.0-4.1) 0.5 (-0.9-1.1) 0.5 
100HzAD (kg) 9.8 (8.0-14.4) 8.6 (6.7-19.2) -1.1 (-3.9-4.6) 0.9 
100HzADpred (kg) 21.8 (17.9-26.6)
# 
19.3 (14.8-24.1)
# 
-2.9 (-4.4- -1.6) 0.01 
100HzAD%pred (%) 56.0 (43.2-64.1)
# 
51.2 (34.7-77.7)
# 
12.1 (-17.2-23.9) 0.6 
TwAD/MRR (kg/s) 0.002±0.0008 0.002±0.0009 -0.0003±0.0009 0.2 
TACSA (mm
2
)  921.8  
(752.2-1055.0) 
 800.8  
(678.8-961.1) 
 -84.3 (-133.4- -54.2) 0.005 
TAEI (AU)  47.4 (39.3-51.4)  42.2 (39.1-52.6)  2.3 (-3.6-7.5) 0.5 
TAEI(SD) (AU)  29.1 (26.1-32.1)  27.6 (24.4-33.1)  -0.2 (-2.0-4.0) 0.9 
TAPA (°)  7.1 (6.8-7.9)  7.1 (6.7-7.7)  -0.1 (-0.6-0.3) 0.7 
TASCthickness (cm)  0.3 (0.3-0.4)  0.3 (0.2-0.5)  -0.02 (-0.06-0.1) 0.6 
TwAD/TACSA (g/mm
2
) 3.5 (2.1-4.0) 3.9 (2.3-5.3) 0.8 (-0.5-2.0) 0.2 
100HzAD/TACSA (g/mm
2
) 13.2 (10.5-16.4) 11.7 (8.9-20.0) 1.8 (-4.3-5.9) 0.8 
TwAD:100HzAD 0.3 (0.2-0.4 ) 0.3 (0.2-0.4) 0.01 (-0.04-0.2) 0.2 
RFCSA (mm
2
)* 632.2 (511.4-837.3)  553.8 (394.6-621.1)  -95.75  
(-199.9- -48.8) 
0.0049 
RFEI (AU)*  56.3 (50.6-61.3)  47.5 (41.5-58.2) -5.9 (-14.8-   -1.7) 0.02 
RFEI(SD) (AU)*  32.0 (29.1-34.9) 26.3 (23.6-29.9)  -5.3 (-10.5-   -0.8) 0.03 
RFPA (°)*  7.3 (7.0-8.0)  7.4 (6.3-8.2)  -0.2 (-0.8-0.9) 0.9 
RFSCthickness (cm)* 0.89 (0.62-1.21) 0.95 (0.74-1.19) -0.02 (-0.12-0.29) 1.0 
Data are presented as median (interquartile range).  n=13.  p values derived from  Wilcoxon signed rank tests (non-parametric data) and 
represent differences between testing occasion 1 and 2.  *n=12: complete rectus femoris muscle architecture data not acquired in one 
patient due to obesity and rectus femoris pennation angle not measurable in a further four patients due to poor quality images..  
#
 
Observed values significantly reduced compared to predicted on both testing occasions; p=0.0002 (Testing occasion 1) and p=0.008 
(Testing occasion 2).    
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Abbreviations: TwAD = twitch ankle dorsiflexor force.  100HzAD = 100Hz ankle dorsiflexor flexor force.  MRR = maximum relaxation rate.   
TACSA = tibialis anterior cross-sectional area.  TAEI(SD) = tibialis anterior echogenicity (standard deviation).  TAPA = tibialis anterior pennation 
angle.  TAsc thickness = tibialis anterior subcutaneous thickness.  RFCSA = rectus femoris cross-sectional area.  RFEI(SD) = rectus femoris 
echogenicity (standard deviation).  RFPA = rectus femoris pennation angle.  RFsc thickness = rectus femoris subcutaneous thickness 
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